Navigation Links
DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
Date:6/29/2011

CAMBRIDGE, Mass., June 29, 2011 /PRNewswire/ -- In September 2010, the DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the NASA Facilitated Access to the Space Environment for Technology (FAST) program.  NASA recently followed that experiment with a $190,000 contract to DMI to analyze data from the parabolic flights.

According to DMI's Chief Scientific Officer Eugene Y. Chan, the reduced gravity experiments "yielded [fantastic] data, which will aid DMI in developing our rHEALTH sensor for use as a universal biomedical laboratory in future space environments."

Based on DMI's successful work under a pair of Phase II Small Business Innovation Research Program contracts designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood, DMI's rHEALTH sensor has been identified by NASA as a viable approach for performing blood and urine analysis on the International Space Station. Rather than relying on ground-based analysis, NASA is promoting the development of the rHEALTH sensor to provide on-orbit analysis capabilities.  The device will directly impact all biomedical research on ISS, and it may also play a critical role in medical and environmental monitoring.  

A second contract, Universal In-Flight Health Diagnostic Technology -- this one in the amount of $420,000 -- was also recently awarded to DMI, to perform clinical validation on white blood cells.  The goal of the contract will be to develop the capabilities to validate the sensor's white blood cell counts, from fingerstick human blood samples, against a recognized medical standard. This award will be funded by HHC (NASA Human Health and Countermeasures) and administered by the NASA Glenn Research Center.

The rHEALTH sensor also has significant dual-use terrestrial applications, such as real-time health monitoring at a patient's bedside or in a doctor's office, allowing for critical clinical interventions in acute situations.

About the DNA Medicine Institute

DMI utilizes an interdisciplinary, multi-faceted approach to innovation that draws upon diverse and disparate fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering. Its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care. It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation. For more information, visit: www.dnamedinstitute.com.


'/>"/>
SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes
2. aTyr Pharma Honored with Red Herring 100 North America Award for Discovering and Developing Innovative Medicines Based on Physiocrine Biology
3. Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities
4. Bureau of Prescription Health Gives the Whole Truth (and Nothing But) About Free Medicine at FreeMedicine.com
5. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
6. The Institute for Specialized Medicine Launches GLUTEN-FREE REMEDIES, a New Line of Gluten-free Food Supplements and Herbs.
7. Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
8. BioLife Solutions Announces Expanded Customer Base in the High Growth Regenerative Medicine Market
9. Consortium Opens Landmark Personalized Medicine Childrens Cancer Trial
10. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
11. Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... Feb. 4, 2016  Aethlon Medical, Inc. (Nasdaq: ... biofiltration devices to treat life-threatening diseases, today announced ... ended December 31, 2015. --> ... set forth in our last quarterly call, we ... our long-term objective to establish the Aethlon Hemopurifier® ...
(Date:2/4/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... investigational kinase medicines for patients with genomically defined ... of directors of Lonnel Coats , a ... industry-related experience. Jeffrey Albers , ... strategic experience developing and commercializing numerous oncology products ...
Breaking Medicine Technology:
(Date:2/6/2016)... ... February 06, 2016 , ... Shark Finds ... the launch of a new DRTV campaign with Belly Bands. , Having a dog ... from sprays to puppy pads and find nothing works, get Belly Bands, the ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 ... ... today announced the availability of the company's lighter, sleeker next generation LYNX VR ... assembly plant. , Improvements in design and manufacturing not only reduce the ...
(Date:2/5/2016)... ... 05, 2016 , ... The Muscular Dystrophy Association and Sailormen ... the 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise ... related diseases that severely limit strength and mobility. , Now through March ...
(Date:2/5/2016)... ... 05, 2016 , ... After years as an active staff surgeon and having ... surgeon Dr. Wayne Carman transitioned to chief of the Division of Plastic Surgery at ... term as chief and began a second three-year term in January of 2016. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... The American public tends to ... may be safer than regular municipal or well water. The recent experience with lead ... Kleyne, could go a long way toward increasing public acceptance of recycled waste water ...
Breaking Medicine News(10 mins):